OCRELIZUMAB vs OFATUMUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OCRELIZUMAB vs OFATUMUMAB: Safety Overview
| Metric | OCRELIZUMAB | OFATUMUMAB |
|---|---|---|
| Total FAERS Reports | 56,186 | 29,913 |
| Deaths Reported | 1,406 | 695 |
| Death Rate | 2.5% | 2.3% |
| Hospitalizations | 10,364 | 3,616 |
| Average Patient Age | 47.2 yrs | 47.5 yrs |
| % Female Patients | 72.5% | 74.9% |
| Manufacturer | Genentech, Inc. | Novartis Pharmaceuticals Corporation |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Prescription | Prescription |